SAN ANTONIO — Delayed and inaccurate diagnoses often plague patients with eosinophilic disorders, but online communities can help them cope, according to data presented at the American Academy of ...

The researchers compiled data from studies of lirentelimab, mepolizumab, reslizumab, and benralizumab, highlighting the difficulties in finding an effective approach with eosinophil-targeted ...

Please provide your email address to receive an email when new articles are posted on . The most common symptom of EoE before pregnancy was dysphagia, followed by reflux and pain. Half of the patients ...

The good news: a monoclonal antibody treatment called benralizumab proved quite effective in a clinical trial at depleting the number of eosinophils found in the blood and digestive tract tissues of ...

VANCOUVER, British Columbia -- Treatment with higher-exposure dupilumab (Dupixent) led to sustained improvements in the reduction of peak esophageal intraepithelial eosinophil counts among children ...

Thus, a chronic immune-mediated inflammatory disorder such as EoE could increase the risk of developing esophageal cancer. 11 Furthermore, patients with chronic eosinophilic disorders may be at risk ...

Background and Aim Allergies have been implicated in the pathogenesis of eosinophilic gastrointestinal disorders, although it remains unknown what type of allergen is closely associated with their ...

Concurrent allergic diseases were seen in 5 (27.8%) patients with EoE and 16 (69.6%) with EGE, showing a significantly higher rate for EGE (P < 0.01) (Table 1). Bronchial asthma and food allergies ...